Hashimotos Thyroiditis Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: H292D50BE851EN
Market Monitor Global

Abstracts

Hashimoto's thyroiditis one of the most prevalent and common autoimmune disease. The individual suffering from Hashimoto’s thyroiditis has his/her own immune system attack the thyroid gland leading to chronic destruction of the thyroid gland. This causes inflammation and reduces the secretion of thyroid hormones. Insufficient thyroid hormones result in hypothyroidism.

This report contains market size and forecasts of Hashimotos Thyroiditis Drug in Global, including the following market information:

Global Hashimotos Thyroiditis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hashimotos Thyroiditis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hashimotos Thyroiditis Drug include LGM Pharma, Merck, Sichuan Hairong Pharmaceutical, Jerome Stevens Pharmaceuticals, Pfizer, Manus Aktteva, Shenzhen Zhonglian Pharmaceutical, Menarini and Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hashimotos Thyroiditis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hashimotos Thyroiditis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hashimotos Thyroiditis Drug Market Segment Percentages, by Type, 2021 (%)

• Capsule
• Tablet
• Powder

Global Hashimotos Thyroiditis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hashimotos Thyroiditis Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Hashimotos Thyroiditis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hashimotos Thyroiditis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hashimotos Thyroiditis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hashimotos Thyroiditis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• LGM Pharma
• Merck
• Sichuan Hairong Pharmaceutical
• Jerome Stevens Pharmaceuticals
• Pfizer
• Manus Aktteva
• Shenzhen Zhonglian Pharmaceutical
• Menarini
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hashimotos Thyroiditis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hashimotos Thyroiditis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HASHIMOTOS THYROIDITIS DRUG OVERALL MARKET SIZE

2.1 Global Hashimotos Thyroiditis Drug Market Size: 2021 VS 2028
2.2 Global Hashimotos Thyroiditis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hashimotos Thyroiditis Drug Players in Global Market
3.2 Top Global Hashimotos Thyroiditis Drug Companies Ranked by Revenue
3.3 Global Hashimotos Thyroiditis Drug Revenue by Companies
3.4 Top 3 and Top 5 Hashimotos Thyroiditis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hashimotos Thyroiditis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hashimotos Thyroiditis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Hashimotos Thyroiditis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hashimotos Thyroiditis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hashimotos Thyroiditis Drug Market Size Markets, 2021 & 2028
  4.1.2 Capsule
  4.1.3 Tablet
  4.1.4 Powder
4.2 By Type - Global Hashimotos Thyroiditis Drug Revenue & Forecasts
  4.2.1 By Type - Global Hashimotos Thyroiditis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Hashimotos Thyroiditis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hashimotos Thyroiditis Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Hashimotos Thyroiditis Drug Revenue & Forecasts
  5.2.1 By Application - Global Hashimotos Thyroiditis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Hashimotos Thyroiditis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hashimotos Thyroiditis Drug Market Size, 2021 & 2028
6.2 By Region - Global Hashimotos Thyroiditis Drug Revenue & Forecasts
  6.2.1 By Region - Global Hashimotos Thyroiditis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Hashimotos Thyroiditis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hashimotos Thyroiditis Drug Revenue, 2017-2028
  6.3.2 US Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.3.3 Canada Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.3.4 Mexico Hashimotos Thyroiditis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hashimotos Thyroiditis Drug Revenue, 2017-2028
  6.4.2 Germany Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.4.3 France Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.4.4 U.K. Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.4.5 Italy Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.4.6 Russia Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.4.8 Benelux Hashimotos Thyroiditis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hashimotos Thyroiditis Drug Revenue, 2017-2028
  6.5.2 China Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.5.3 Japan Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.5.4 South Korea Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.5.6 India Hashimotos Thyroiditis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hashimotos Thyroiditis Drug Revenue, 2017-2028
  6.6.2 Brazil Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.6.3 Argentina Hashimotos Thyroiditis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hashimotos Thyroiditis Drug Revenue, 2017-2028
  6.7.2 Turkey Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.7.3 Israel Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Hashimotos Thyroiditis Drug Market Size, 2017-2028
  6.7.5 UAE Hashimotos Thyroiditis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 LGM Pharma
  7.1.1 LGM Pharma Corporate Summary
  7.1.2 LGM Pharma Business Overview
  7.1.3 LGM Pharma Hashimotos Thyroiditis Drug Major Product Offerings
  7.1.4 LGM Pharma Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.1.5 LGM Pharma Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Hashimotos Thyroiditis Drug Major Product Offerings
  7.2.4 Merck Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Sichuan Hairong Pharmaceutical
  7.3.1 Sichuan Hairong Pharmaceutical Corporate Summary
  7.3.2 Sichuan Hairong Pharmaceutical Business Overview
  7.3.3 Sichuan Hairong Pharmaceutical Hashimotos Thyroiditis Drug Major Product Offerings
  7.3.4 Sichuan Hairong Pharmaceutical Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.3.5 Sichuan Hairong Pharmaceutical Key News
7.4 Jerome Stevens Pharmaceuticals
  7.4.1 Jerome Stevens Pharmaceuticals Corporate Summary
  7.4.2 Jerome Stevens Pharmaceuticals Business Overview
  7.4.3 Jerome Stevens Pharmaceuticals Hashimotos Thyroiditis Drug Major Product Offerings
  7.4.4 Jerome Stevens Pharmaceuticals Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.4.5 Jerome Stevens Pharmaceuticals Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Hashimotos Thyroiditis Drug Major Product Offerings
  7.5.4 Pfizer Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Manus Aktteva
  7.6.1 Manus Aktteva Corporate Summary
  7.6.2 Manus Aktteva Business Overview
  7.6.3 Manus Aktteva Hashimotos Thyroiditis Drug Major Product Offerings
  7.6.4 Manus Aktteva Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.6.5 Manus Aktteva Key News
7.7 Shenzhen Zhonglian Pharmaceutical
  7.7.1 Shenzhen Zhonglian Pharmaceutical Corporate Summary
  7.7.2 Shenzhen Zhonglian Pharmaceutical Business Overview
  7.7.3 Shenzhen Zhonglian Pharmaceutical Hashimotos Thyroiditis Drug Major Product Offerings
  7.7.4 Shenzhen Zhonglian Pharmaceutical Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.7.5 Shenzhen Zhonglian Pharmaceutical Key News
7.8 Menarini
  7.8.1 Menarini Corporate Summary
  7.8.2 Menarini Business Overview
  7.8.3 Menarini Hashimotos Thyroiditis Drug Major Product Offerings
  7.8.4 Menarini Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.8.5 Menarini Key News
7.9 Novartis
  7.9.1 Novartis Corporate Summary
  7.9.2 Novartis Business Overview
  7.9.3 Novartis Hashimotos Thyroiditis Drug Major Product Offerings
  7.9.4 Novartis Hashimotos Thyroiditis Drug Revenue in Global Market (2017-2022)
  7.9.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hashimotos Thyroiditis Drug Market Opportunities & Trends in Global Market
Table 2. Hashimotos Thyroiditis Drug Market Drivers in Global Market
Table 3. Hashimotos Thyroiditis Drug Market Restraints in Global Market
Table 4. Key Players of Hashimotos Thyroiditis Drug in Global Market
Table 5. Top Hashimotos Thyroiditis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hashimotos Thyroiditis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hashimotos Thyroiditis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hashimotos Thyroiditis Drug Product Type
Table 9. List of Global Tier 1 Hashimotos Thyroiditis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hashimotos Thyroiditis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hashimotos Thyroiditis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hashimotos Thyroiditis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hashimotos Thyroiditis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hashimotos Thyroiditis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hashimotos Thyroiditis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hashimotos Thyroiditis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2023-2028
Table 30. LGM Pharma Corporate Summary
Table 31. LGM Pharma Hashimotos Thyroiditis Drug Product Offerings
Table 32. LGM Pharma Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Hashimotos Thyroiditis Drug Product Offerings
Table 35. Merck Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Sichuan Hairong Pharmaceutical Corporate Summary
Table 37. Sichuan Hairong Pharmaceutical Hashimotos Thyroiditis Drug Product Offerings
Table 38. Sichuan Hairong Pharmaceutical Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 39. Jerome Stevens Pharmaceuticals Corporate Summary
Table 40. Jerome Stevens Pharmaceuticals Hashimotos Thyroiditis Drug Product Offerings
Table 41. Jerome Stevens Pharmaceuticals Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Hashimotos Thyroiditis Drug Product Offerings
Table 44. Pfizer Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Manus Aktteva Corporate Summary
Table 46. Manus Aktteva Hashimotos Thyroiditis Drug Product Offerings
Table 47. Manus Aktteva Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 48. Shenzhen Zhonglian Pharmaceutical Corporate Summary
Table 49. Shenzhen Zhonglian Pharmaceutical Hashimotos Thyroiditis Drug Product Offerings
Table 50. Shenzhen Zhonglian Pharmaceutical Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 51. Menarini Corporate Summary
Table 52. Menarini Hashimotos Thyroiditis Drug Product Offerings
Table 53. Menarini Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Novartis Corporate Summary
Table 55. Novartis Hashimotos Thyroiditis Drug Product Offerings
Table 56. Novartis Hashimotos Thyroiditis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hashimotos Thyroiditis Drug Segment by Type in 2021
Figure 2. Hashimotos Thyroiditis Drug Segment by Application in 2021
Figure 3. Global Hashimotos Thyroiditis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hashimotos Thyroiditis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hashimotos Thyroiditis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hashimotos Thyroiditis Drug Revenue in 2021
Figure 8. By Type - Global Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 12. US Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 24. China Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hashimotos Thyroiditis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hashimotos Thyroiditis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. LGM Pharma Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sichuan Hairong Pharmaceutical Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Jerome Stevens Pharmaceuticals Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Manus Aktteva Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Shenzhen Zhonglian Pharmaceutical Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Menarini Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis Hashimotos Thyroiditis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)